Where’s the Brexit? UK clinical research industry charts path ahead of EU withdrawal

By Melissa Fassbender contact

- Last updated on GMT

Clinical research professionals look to prepare for post-Brexit challenges. (Image: iStock/lumyaisweet)
Clinical research professionals look to prepare for post-Brexit challenges. (Image: iStock/lumyaisweet)

Related tags: Clinical research, United kingdom

Industry leaders gathered at an Emergency Summit Meeting to discuss the implications of Brexit and the future of clinical research in the UK.

IAOCR, an accrediting organization for the international clinical research industry, called the meeting to identify preparatory action ahead of the UK’s departure from the European Union.

Jacqueline Johnson North, CEO of IAOCR, told us the Emergency Summit Meeting’s goal was identify “a clear plan about how the Clinical Research Industry can effectively navigate the imminent political changes that will come with Brexit​.”

Areas of focus include identifying potential working challenges for the EU clinical research workforce​ in the UK and vice-versa; how the industry and Governments will safeguard the future of clinical trials​; and what challenges and/or opportunities might arise.

Our intention is to create a task force that will develop a practical solution to ensure that the clinical research industry proactively responds to these changes and mitigates potential challenges before they arise,” ​said Johnson North.

“We are on the horizon of a significant political and environmental change as Britain’s exit from the EU begins, and this will have a big impact on the Clinical Research sector."

The summit meeting was held last week on April 5th​, at which time industry stakeholders identified key challenges and opportunities that the clinical research sector needs to consider.

“To directly hear from and debate with industry leaders to identify and prioritize key factors that will be impacted by Brexit was invaluable,” ​said Johnson North.

IAOCR will release more information over the following months about the specific discussion points as it prepares to release a position paper on the issues.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us

Products

View more

Webinars